Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Sep-21 4:30 PM View:  | Park West Asset Management ... 10% Owner | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition (other) | 6,000,000 | -- | -- | (100%) 6.0M to 0 | |
| 30-Aug-21 6:08 PM View: | Wee Wendy Chief Financial Officer | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition | 78,613 | $9.25 | $727,170.00 | (100%) 78.61K to 0 | 0% |
| 30-Aug-21 9:46 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition | 1,709,270 | $9.25 | $15,810,800.00 | (100%) 1.72M to 8.0K | 0% |
| 30-Aug-21 3:45 PM View: | Townsend Raymond Director | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition | 24,928 | $9.25 | $230,584.00 | (100%) 24.93K to 0 | 0% |
| 30-Aug-21 5:43 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition | 145,835 | $9.25 | $1,348,970.00 | (100%) 145.84K to 0 | 0% |
| 30-Aug-21 9:46 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition | 8,000 | $9.25 | $74,000.00 | (100%) 8.0K to 0 | 0% |
| 30-Aug-21 5:17 PM View: | Zhan Hangjun Chief Scientific Officer | Kindred Biosciences, Inc. (KIN) | 27-Aug-21 | Disposition | 64,306 | $9.25 | $594,830.00 | (100%) 64.31K to 0 | 0% |
| 04-Aug-21 3:00 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 02-Aug-21 | Market Sale (Planned) | 40,000 | $9.21 | $368,240.00 | (3%) 1.57M to 1.53M | (< 1%) |
| 04-Aug-21 3:00 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 22-Jul-21 | Gift | 320,000 | -- | -- | (17%) 1.89M to 1.57M | |
| 07-Jul-21 12:02 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 02-Jul-21 | Market Sale (Planned) | 40,000 | $9.18 | $367,080.00 | (2%) 1.93M to 1.89M | (< 1%) |
| 17-Jun-21 9:30 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 16-Jun-21 | Market Sale (Planned) | 40,000 | $9.18 | $367,268.00 | (2%) 1.97M to 1.93M | (< 1%) |
| 07-Jun-21 6:58 PM View: | Park West Asset Management ... 10% Owner | Kindred Biosciences, Inc. (KIN) | 04-Jun-21 | Market Sale | 345,383 | $6.95 | $2,400,580.00 | (5%) 6.35M to 6.0M | (33%) |
| 07-Jun-21 6:58 PM View: | Park West Asset Management ... 10% Owner | Kindred Biosciences, Inc. (KIN) | 03-Jun-21 | Market Sale | 69,600 | $6.80 | $473,092.00 | (1%) 6.41M to 6.35M | (36%) |
| 18-Mar-21 4:35 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 17-Mar-21 | Market Option Sale (Planned) | 8,396 | $5.00 | $41,996.80 | (6%) 152.23K to 143.84K | (85%) |
| 18-Mar-21 4:35 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 17-Mar-21 | Option Exercise | 8,396 | $0.32 | $2,686.72 | 6% 143.84K to 152.23K | |
| 23-Feb-21 4:55 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 22-Feb-21 | Option Exercise | 4,622 | $0.32 | $1,479.04 | 3% 143.84K to 148.46K | |
| 23-Feb-21 4:55 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 22-Feb-21 | Market Option Sale (Planned) | 4,622 | $5.00 | $23,110.00 | (3%) 148.46K to 143.84K | (85%) |
| 23-Feb-21 4:55 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 19-Feb-21 | Option Exercise | 5 | $0.32 | $1.60 | < 1% 143.84K to 143.84K | |
| 23-Feb-21 4:55 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 19-Feb-21 | Market Option Sale (Planned) | 5 | $5.00 | $25.00 | (< 1%) 143.84K to 143.84K | (85%) |
| 03-Feb-21 3:20 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 01-Feb-21 | Option Exercise | 12,500 | -- | -- | < 1% 1.97M to 1.98M | |
| 03-Feb-21 3:20 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 01-Feb-21 | Payment of Exercise | 6,582 | $5.00 | $32,910.00 | (< 1%) 1.98M to 1.97M | (85%) |
| 01-Feb-21 6:00 PM View: | Park West Asset Management ... 10% Owner | Kindred Biosciences, Inc. (KIN) | 29-Jan-21 | Market Sale | 3,300 | $5.07 | $16,731.00 | (< 1%) 6.42M to 6.41M | (82%) |
| 01-Feb-21 6:00 PM View: | Park West Asset Management ... 10% Owner | Kindred Biosciences, Inc. (KIN) | 28-Jan-21 | Market Sale | 210,472 | $5.25 | $1,104,980.00 | (3%) 6.63M to 6.42M | (76%) |
| 26-Jan-21 8:36 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 23-Jan-21 | Payment of Exercise | 13,163 | $4.93 | $64,893.60 | (< 1%) 1.98M to 1.97M | (87%) |
| 26-Jan-21 8:50 PM View: | Zhan Hangjun Chief Scientific Officer | Kindred Biosciences, Inc. (KIN) | 23-Jan-21 | Payment of Exercise | 3,385 | $4.93 | $16,688.00 | (8%) 42.69K to 39.31K | (87%) |
| 26-Jan-21 9:06 PM View: | Wee Wendy Chief Financial Officer | Kindred Biosciences, Inc. (KIN) | 23-Jan-21 | Payment of Exercise | 3,385 | $4.93 | $16,688.00 | (6%) 52.42K to 49.04K | (87%) |
| 26-Jan-21 8:36 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 22-Jan-21 | Option Exercise | 37,500 | -- | -- | 2% 1.96M to 2.0M | |
| 26-Jan-21 8:50 PM View: | Zhan Hangjun Chief Scientific Officer | Kindred Biosciences, Inc. (KIN) | 22-Jan-21 | Option Exercise | 6,250 | -- | -- | 16% 39.83K to 46.08K | |
| 26-Jan-21 9:06 PM View: | Wee Wendy Chief Financial Officer | Kindred Biosciences, Inc. (KIN) | 22-Jan-21 | Option Exercise | 7,500 | -- | -- | 15% 48.99K to 56.49K | |
| 26-Jan-21 8:50 PM View: | Zhan Hangjun Chief Scientific Officer | Kindred Biosciences, Inc. (KIN) | 22-Jan-21 | Payment of Exercise | 3,385 | $4.93 | $16,688.00 | (7%) 46.08K to 42.69K | (87%) |
| 26-Jan-21 9:06 PM View: | Wee Wendy Chief Financial Officer | Kindred Biosciences, Inc. (KIN) | 22-Jan-21 | Payment of Exercise | 4,062 | $4.93 | $20,025.70 | (7%) 56.49K to 52.42K | (87%) |
| 26-Jan-21 8:36 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 22-Jan-21 | Payment of Exercise | 19,744 | $4.93 | $97,337.90 | (< 1%) 2.0M to 1.98M | (87%) |
| 20-Jan-21 6:58 PM View: | Zhan Hangjun Chief Scientific Officer | Kindred Biosciences, Inc. (KIN) | 17-Jan-21 | Payment of Exercise | 3,385 | $4.95 | $16,755.80 | (8%) 43.21K to 39.83K | (87%) |
| 20-Jan-21 7:11 PM View: | Wee Wendy Chief Financial Officer | Kindred Biosciences, Inc. (KIN) | 17-Jan-21 | Payment of Exercise | 3,385 | $4.95 | $16,755.80 | (6%) 52.35K to 48.97K | (87%) |
| 20-Jan-21 7:20 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 17-Jan-21 | Payment of Exercise | 21,128 | $4.95 | $104,584.00 | (1%) 1.98M to 1.96M | (87%) |
| 20-Jan-21 7:20 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 17-Jan-21 | Option Exercise | 37,500 | -- | -- | 2% 1.95M to 1.98M | |
| 20-Jan-21 6:58 PM View: | Zhan Hangjun Chief Scientific Officer | Kindred Biosciences, Inc. (KIN) | 17-Jan-21 | Option Exercise | 6,250 | -- | -- | 17% 36.96K to 43.21K | |
| 20-Jan-21 7:11 PM View: | Wee Wendy Chief Financial Officer | Kindred Biosciences, Inc. (KIN) | 17-Jan-21 | Option Exercise | 6,250 | -- | -- | 14% 46.1K to 52.35K | |
| 15-Jan-21 6:27 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 14-Jan-21 | Market Option Sale (Planned) | 13,023 | $5.00 | $65,115.00 | (8%) 156.86K to 143.84K | (85%) |
| 15-Jan-21 6:27 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 14-Jan-21 | Option Exercise | 13,023 | $0.32 | $4,167.36 | 9% 143.84K to 156.86K | |
| 08-Jan-21 7:03 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 07-Jan-21 | Option Exercise | 39,069 | $0.32 | $12,502.10 | 27% 143.84K to 182.9K | |
| 08-Jan-21 7:03 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 07-Jan-21 | Market Option Sale | 39,069 | $5.00 | $195,349.00 | (21%) 182.9K to 143.84K | (85%) |
| 08-Oct-20 9:11 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 07-Oct-20 | Option Exercise | 12,508 | $0.32 | $4,002.56 | 9% 143.84K to 156.34K | |
| 08-Oct-20 9:11 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 07-Oct-20 | Market Option Sale | 12,508 | $5.01 | $62,627.60 | (8%) 156.34K to 143.84K | (84%) |
| 24-Sep-20 6:45 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 22-Sep-20 | Market Option Sale | 515 | $5.00 | $2,575.00 | (< 1%) 144.35K to 143.84K | (84%) |
| 24-Sep-20 6:45 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 22-Sep-20 | Option Exercise | 515 | $0.32 | $164.80 | < 1% 143.84K to 144.35K | |
| 03-Aug-20 8:46 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 31-Jul-20 | Payment of Exercise | 59,498 | $3.29 | $195,748.00 | (29%) 203.33K to 143.84K | (180%) |
| 03-Aug-20 8:46 PM View: | Bevers Denise Director | Kindred Biosciences, Inc. (KIN) | 31-Jul-20 | Option Exercise | 95,000 | -- | -- | 88% 108.33K to 203.33K | |
| 30-Jun-20 9:30 PM View: | Park West Asset Management ... 10% Owner | Kindred Biosciences, Inc. (KIN) | 26-Jun-20 | Market Sale | 115,136 | $4.71 | $542,291.00 | (2%) 6.74M to 6.63M | (96%) |
| 13-Feb-20 4:28 PM View: | Chin Richard Chief Executive Officer Director | Kindred Biosciences, Inc. (KIN) | 11-Feb-20 | Payment of Exercise | 4,317 | $9.22 | $39,802.70 | (< 1%) 1.95M to 1.95M | < 1% |
